Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/10/046531
CTRI/2022/10/046531
Completed
Phase 3

EVALUATION OF CLINICAL AND ANTI-INFLAMMATORY EFFECT OF BUKHOOR (MEDICATED STEAM ) IN THE MANAGMENT OF NON-SPECIFIC LOW BACK PAIN (WAJA’AL-ZAHR).

Ajmal khan Tibbiya college0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ajmal khan Tibbiya college
Enrollment
60
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 22, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Ajmal khan Tibbiya college

Eligibility Criteria

Inclusion Criteria

  • •? Diagnosed patient of nonspecific low back pain.
  • •? Patient who have agreed to sign informed consent and follow up the protocol.
  • •? Patient who will be ready to discontinue NSAIDS or any other medications for any other conditions.
  • •? Patient who will be having pain scale of minimum 30 mm.
  • •? VAS score will be used to quantify pain and restriction of movement as mild, moderate and severe.

Exclusion Criteria

  • •? Patients below the age of 18 and above the age of 65 years.
  • •? Pregnancy and lactations.
  • •? Patients with systemic disorders like CRF, CLD and cardiac dysfunctions.
  • •? Uncontrolled diabetes mellitus
  • •? History of urticaria.
  • •? Any skin disease on the localised area.
  • •? Other types of Arthritis (Tubercular, infective arthritis etc).
  • •Patients who have low back pain due to specific and known etiological causes (infection, tumour, osteoporosis, ankylosing spondylitis, fracture).
  • •?Patients who are planning for vertebra surgery.
  • •?Patients having any psychological disorders.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Evaluation of efficacy and anti-inflammatory action of PlacentrexTM in women with inflammatory Pap smears.
CTRI/2010/091/000197ALBERT DAVID LTD KOLKATA150
Recruiting
Phase 3
A study on therapeutic and anti-inflammatory effects of probiotic in asthmatic patients referred to kowsar semnan hospitalAsthmatic.Mild intermittent asthma with status asthmaticusJ45.22
IRCT20151228025732N54Semnan University of Medical Sciences60
Completed
Not Applicable
Clinical study concerning anti-inflammatory effect of fixed dose therapy by budesonide/formoterol combination inhaler for moderate persistent asthmatics.Bronchial asthma
JPRN-UMIN000011853ational Center for Global Health and Medicine50
Not yet recruiting
Phase 4
Comparision of two mouthrinses in orthodontic patients
CTRI/2018/02/011847adimpalli Harshita
Active, not recruiting
Not Applicable
ntersuchung der antiinflammatorischen Eigenschaften von Clopidogrel im Vergleich zu Acetylsalicylsäure bei Patienten mit chronischer ischämischer KardiomyopathieDas Ziel dieser Untersuchung ist es, zu evaluieren, ob und welche antiinflammatorischen Effekte Clopidogrel 75 mg im Vergleich zu Acetylalicylsäure (ASS) 100 mg bei Patienten mit chronischer ischämischer Kardiomyopathie aufweist. Untersucht werden soll dieses mittels Evaluation der peripheren endothelialen Stickstoffmonoxid-(NO) Bioverfügbarkeit sowie durch Bestimmung der Spiegel zirkulierender Peroxidasen wie Myeloperoxidase (MPO) oder Xanthin Oxidase (XO).
EUCTR2006-000001-27-DEniversitäres Herzzentrum, Klinik für Kardiologie und Angiologie